XNYSDNMR
Market cap6mUSD
Dec 31, Last price
2.10USD
1D
-49.15%
1Q
368.75%
IPO
-78.26%
Name
Danimer Scientific Inc
Chart & Performance
Profile
Danimer Scientific, Inc., a performance polymer company, develops, produces, and provides bioplastic replacements for traditional petroleum-based plastics. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative used in a range of plastic applications, including films, straws, food containers, and other things under the Nodax brand name; polylactic acid-based resins for coating disposable paper cups; and other biopolymers. The company offers its products for biopolymers, including additives, aqueous coatings, fibers, filaments, films, thermoforming, and injection-molded articles. It also markets its products to consumer packaging brand owners, converters, and manufacturers in the plastics industry. Danimer Scientific, Inc. was founded in 2004 and is headquartered in Bainbridge, Georgia.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
Income | ||||||
Revenues | 46,684 -12.28% | 53,218 -9.41% | ||||
Cost of revenue | 102,886 | 95,571 | ||||
Unusual Expense (Income) | ||||||
NOPBT | (56,202) | (42,353) | ||||
NOPBT Margin | ||||||
Operating Taxes | 319 | (810) | ||||
Tax Rate | ||||||
NOPAT | (56,521) | (41,543) | ||||
Net income | (155,473) -13.51% | (179,758) 199.06% | ||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | 225 | (472) | ||||
BB yield | -0.22% | 0.26% | ||||
Debt | ||||||
Debt current | 8,042 | 5,309 | ||||
Long-term debt | 428,627 | 333,963 | ||||
Deferred revenue | ||||||
Other long-term liabilities | 1,025 | 659 | ||||
Net debt | 377,499 | 243,425 | ||||
Cash flow | ||||||
Cash from operating activities | (47,264) | (61,837) | ||||
CAPEX | (27,685) | (164,486) | ||||
Cash from investing activities | (27,663) | (182,482) | ||||
Cash from financing activities | 84,030 | 21,752 | ||||
FCF | (47,295) | (207,310) | ||||
Balance | ||||||
Cash | 59,170 | 62,792 | ||||
Long term investments | 33,055 | |||||
Excess cash | 56,836 | 93,186 | ||||
Stockholders' equity | (454,111) | (298,638) | ||||
Invested Capital | 1,144,561 | 990,061 | ||||
ROIC | ||||||
ROCE | ||||||
EV | ||||||
Common stock shares outstanding | 102,002 | 101,095 | ||||
Price | 1.02 -43.02% | 1.79 -78.99% | ||||
Market cap | 104,042 -42.51% | 180,961 -77.18% | ||||
EV | 481,541 | 424,386 | ||||
EBITDA | (27,144) | (22,267) | ||||
EV/EBITDA | ||||||
Interest | 112,252 | |||||
Interest/NOPBT |